Metraipolis › archive › dc_2ee1500b4eeb

Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma — Europe PMC PMID:42317344

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42317344
DOI
10.3389/fimmu.2026.1861310
License (as archived)
solo-consultazione
Archived
2026-10-31T18:49:13.180Z
SHA-256 of the archived text
a62237421fd6ad65c194057ef0645601f24b24ec3ba08fdb0f0fe0dbd1eb59bc
Stable URL of this page
https://metraipolis.com/documento/dc_2ee1500b4eeb

How to cite

Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma — Europe PMC PMID:42317344 — Europe PMC (en), https://europepmc.org/article/MED/42317344 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ee1500b4eeb (Metraipolis archive dc_2ee1500b4eeb, sha256 a62237421fd6ad65c194057ef0645601f24b24ec3ba08fdb0f0fe0dbd1eb59bc)
BibTeX
@misc{dc2ee1500b4eeb,
  title = {Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma — Europe PMC PMID:42317344},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317344},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ee1500b4eeb; sha256 a62237421fd6ad65c194057ef0645601f24b24ec3ba08fdb0f0fe0dbd1eb59bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317344. Agents can read the archived copy with the MCP tool read_document.